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A B S T R A C T
Diabetes represents one of the major health concerns, especially in developed countries. Some hormones such as
the stress hormone adrenaline can induce reactive oxygen species (ROS) and may worsen the diabetes.
Therefore, the main aim of the investigation was to find out whether peripheral blood mononuclear cells
(PBMCs) from normal persons have less DNA damage induced by adrenaline (0.1, 1 and 10 μM) in comparison to
PBMCs from obese, prediabetic and diabetic patients. Also, the biochemical parameters of oxidative stress
(TBARS, catalase) and lactate dehydrogenase were monitored. It was observed that higher concentrations of
adrenaline (1 and 10 μM) induced DNA damage in the obese, prediabetic and diabetic groups. In healthy in-
dividuals only the highest concentration of adrenaline caused significant increase in the DNA damage. In
summary, total comet score (TCS) comparison has shown significant differences between groups, and DNA
damaging effects of adrenaline were most evident in diabetic patients. The results of the biochemical analysis
also demonstrate that adrenaline exerts most obvious effects in diabetic individuals which is manifested as
significant change of parameters of oxidative stress. In summary, the obtained results demonstrated that dia-
betics are more sensitive to genotoxic effects of adrenaline and this effect probably resulted from decreased
antioxidative defence mechanisms in various stages of progression through diabetes. Therefore, these results
could contribute to a better understanding of a role of endocrine factors to damage of cellular biomolecules
which could be useful in finding novel therapeutic approaches and lifestyle changes with an aim to lower the
possibility of diabetes complications.
1. Introduction
Diabetes mellitus is a group of metabolic diseases characterised by
hyperglycemia due to a defect in insulin secretion or/and due to a
defect in its effects. International Diabetes Federation (IDF) has de-
scribed diabetes as global epidemic. The most prevalent form of dia-
betes is type 2 diabetes mellitus (T2DM) and it is expected to increase to
439 million by 2030 [1]. One of the important factors which contribute
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to an increased development of T2DM is obesity [2].
Free radicals are formed during normal metabolic processes of
biosynthesis, biodegradation and biotransformation and they have nu-
merous physiological roles, such as: taking part in cell signaling, de-
fense against infective agents, regulation of gene expression [3]. If their
production is uncontrolled and overruns antioxidative capacity of the
cell, a pathological state arises, followed by oxidation of membrane
lipids, cell proteins and DNA. This state may result in production of new
cytotoxic ROS and even the cell death [4]. In diabetic cells, the amount
of glucose oxidized in the Krebs tricarboxylic acid cycle is increased,
leading to an increase in generation of reactive oxygen species (ROS)
and resulting oxidative stress plays a key role in the pathogenesis and
progression of diabetes and diabetic complications [5].
Hyperglycemia induces excessive production of superoxide anion in
electron transport chain, leading to a numerous metabolic abnormal-
ities and activation of pathways involved in pathogenesis of diabetes
complications [6].
Relatively high concentrations of H2O2 are released at the site of any
kind of inflammation, but also in uninflammed cells (fibroblasts, en-
dothelial cells, chondrocytes) under the influence of cytokines such as
interleukin-1 and TNF-α. Cells are protected from hydrogen peroxide by
powerful enzyme systems such as catalase in peroxisomes and glu-
tathione peroxidase in mitochondrion’s [7].
Catalase is an enzyme with high expression in all tissues. Early and
profound oxidative stress in any organ, especially in pancreas, leads to,
probably compensatory, increase of the activity of antioxidative en-
zymes including catalase [8].
If the hydrogen peroxide is not removed by catalase it can react with
ferric ions (the Fenton reaction) making the more potent hydroxyl ra-
dical. This radical causes mitochondrial membrane damage in situ
leading to loss of ATP production, damage to DNA, cell membrane by
modification of membrane proteins, lipid peroxidation and possibly
irreversible cell destruction. [9].
Accumulating evidence clearly indicates an association between
oxidative stress and T2DM [10]. It has been reported that T2DM pa-
tients show higher oxidative stress which is reflected in significant
changes in parameters of oxidative stress compared to healthy in-
dividuals [11]. Also significant raises in DNA damage of PBMCs in
diabetic patient have been observed [11]. It is interesting that oxidative
stress already exist in prediabetic patients [12]. Therefore, oxidative
stress is thought to play an important role in the progression of diabetes
and its complications such as foot ulcers, myocardial infarction or
cerebrovascular accidents [13].
Adrenaline is a hormone and neurotrasmitter with primary roles in
mobilization of resources in response to emotional and physical stress.
It is also an important regulator of insulin secretion [14]. Adrenaline is
used as an emergency treatment for cardiac arrest, in the treatment of
asthma, allergic reactions and glaucoma [15]. There are reports which
suggest that administration of adrenaline exerts genotoxic effect via
ROS [16]. Moreover, short term (less than 30min) exposure of murine
3T3 cells to stress hormones (including the adrenaline) causes 5 fold
increase in the DNA damage revealed by the Comet assay [17]. One of
the possible mechanisms of elevated ROS is achieved through stimu-
lation of β2 adrenergic receptors [18]. In addition, adrenaline may
undergo autoxidation and form quinone and semiquinone that enter in
redox cycling which results in excess level of ROS and lead to oxidative
stress [19].
Based on the above, we hypothesize that PBMCs of prediabetic and
diabetic individuals may be more sensitive to the DNA damaging effect
of adrenaline and oxidative stress which may result in worsening dia-
betes control. In order to investigate our hypothese, we determined the
genotoxic effects and as parameters of oxidative stress catalase (CAT),
thiobarbituric acid reactive substances (TBARS) and lactate dehy-
drogenase (LDH) after administration of adrenaline in cells from
healthy, obese, prediabetic and diabetic persons. To our knowledge,
this type of study has not been conducted yet and the observed results
may contribute to better understanding the significance of adrenaline in
progression of T2DM.
2. Material and methods
2.1. Study subjects
The present study was conducted on 28 females from 46 to 63 years
old (7 persons in each group with the following mean ± SEM age:
healthy 53.0 ± 3.6; obese 61.0 ± 1.4; prediabetes 53.8 ± 2.3; T2DM
57.0 ± 2.9), who attended the Department of Endocrinology, Diabetes
and Metabolic Diseases in Belgrade. Neither of the subjects had been
ever diagnosed with malignancy, myocardial infarction, cere-
brovascular insult or any other serious complication of diabetes. All of
them were non-smokers, under no medication (except for drugs for
controlling blood sugar level), and without use of any food supple-
ments. All participants were informed about the procedure of the study
and signed a written consent which was approved by the Ethical
committee at the Faculty of Pharmacy (University of Belgrade).
Participants were divided into four groups (7 females in each
group): female individuals with normal blood glucose levels (healthy
group); group with normal blood glucose levels and body mass index
(BMI)≥30.0 kg/m2 (obese group); group with impaired fasting plasma
glucose (5.5 mmol/L < FPG<7mmol/L) (prediabetic group) - ac-
cording to the recommendations of the World Health Definition,
Diagnosis and Classification of Diabetes Mellitus and its Complications
[20] and group selected on the basis of having been diagnosed with
T2DM previously using an oral glucose tolerance test and/or being on
antihyperglycaemic medication (diabetic group). All subjects were
completely physically examined in the morning after an overnight fast.
Some antropometric parameters (body height, body weight, blood
pressure) were measured the same morning, and body mass index was
calculated as weight in kg per square meters of height (m2). Fasting
plasma glucose (FPG) was determined by PAP enzymatic spectro-
photometry at 505 nm, whereas glycosylated hemoglobin (HbA1c) was
determined by capilary electrophoresis on Capillarys 3 Tera device.
2.2. Sampling and cell preparation
Blood samples were withdrawn by venipuncture from female do-
nors. All samples within one group were taken on the same day, and all
tested parameters were done on fresh samples. The blood was diluted
(1:1) with RPMI medium, underlaid with Histopaque 1077 and cen-
trifuged at 1900 g for 15min. The PBMCs layer (buffy coat) was washed
twice in RPMI 1640 medium, each wash was followed by centrifugation
for 10min at 1800g.
2.3. Comet assay
The alkaline version of Comet assay was performed according to
Singh et al. [21] and Tice et al. [22] with minor modifications. Briefly, a
suspension of isolated PBMCs in PBS was treated with adrenaline (0.1,
1, and 10 μM, CAS No. 51-43-4) for 30min at 37 °C. Immediatelly after
the incubation period, the cell viability was checked by Trypan blue
exclusion [23]. Each experiment included a positive control (100 μM
H2O2) and negative control (untreated cells). After incubation, 100 μL
of cell suspension was mixed with 100 μL of 1% low melting point
agarose (LMPA). 90 μL of suspension was casted on a microscope slide
precoated with 1% normal melting agarose and put in the fridge to
solidify. Then the slides were immersed in cold lysis solution at pH 10
(2.5M NaCl, 100mM EDTA, 10mM Tris pH 10, 1% Triton X–100, 10%
DMSO) overnight at 4 °C. After lysis, slides were placed in a horizontal
gel electrophoresis tank to allow DNA unwinding in cold electrophor-
esis buffer (300mM NaOH, 1mM EDTA, pH > 13) for 30min. Elec-
trophoresis was carried out at 4 °C with electric current of 25 V (1.1 V/
cm) for 30min. The slides were then removed from the tray and washed
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with neutralizing buffer (0.4M Tris HCl, pH 7.5) for 5min. The neu-
tralisation was repeated three times. Finally, the slides were fixed with
ice cold methanol, dried and stored. Before analysis, the slides were
rehydrated with ice cold distilled water and stained with ethidium
bromide (20 μg/mL). The slides were examined under a fluorescence
microscope (AxioImager Z1, Carl Zeiss; excitation filter, 515–560 nm;
emission filter, 590 nm). Comet were scored visually as described by
Anderson et al. [24] and expressed as the total comet score (TCS) ac-
cording to Collins [25]. In visual scoring the estimated level of DNA
damage results in five classes of comets: (A) no damage,< 5%; (B) low
level damage, 5–20%; (C) medium level damage, 20–40%; (D) high
level damage, 40–95%; (E) total damage,> 95% („hedgehogs co-
mets“). (Fig.1). TCS is calculated according to the formula:
TCS =1×B + 2×C +3×D + 4×E
where B to E represents percentage of cells with various level of DNA
damage.
2.4. Determination of catalase (CAT)
Catalase activity was assayed in suspension of isolated PBMCs in
PBS after treatment with adrenaline using H2O2 as substrate and ac-
tivity was followed by measuring the decrease in absorbance at 240 nm
[26]. The enzyme activity was expressed in U/mL. Each experiment
included a positive control (100 μM H2O2) and negative control (un-
treated cells).
2.5. Determination of lipid peroxidation (TBARS)
Lipid peroxidation was assessed in suspension of isolated PBMCs in
PBS after treatment with adrenaline, by measuring thiobarbituric acid
reactive substances test (TBARS) according to the methods described by
Gutteridge [27] and Traverso et al. [28]. The assay evaluated the for-
mation of a colored adduct after the stoichiometric reaction between
thiobarbituric acid (TBA) and several lipid derived aldehydes, including
malondialdehyde (MDA). The TBARS level released in the samples was
measured at 535 nm. The results were expressed in nmol/mL. Each
experiment included a positive control (100 μM H2O2) and negative
control (untreated cells).
2.6. Determination of lactate dehydrogenase (LDH)
After the incubation period with adrenaline, the suspension of
PBMCs in PBS was centrifugated for 5min at 2 000 rpm and extra-
cellular LDH determined in the supernatant. Each experiment included
a positive control (100 μM H2O2) and a negative control (untreated
cells). Lactate dehydrogenase was determined by specrophotometry.
The reaction solution (2.0 ml) containing Tris HCl buffer (61.43mM,
pH 7.4) and NADH (0.18 mM) was supplemented with pyruvate
(0.6 mM). The 100 μl of the supernatant was then added in reaction
solution. The extinction was detected at 339 nm after 30 s, 1, 2 and
3min at 25 °C [29]. The enzyme activity was expressed in U/mL.
Fig. 1. DNA damage in various stages of progression through diabetes mellitus type 2: A – normal persons; B – obese with normal glycoregulation; C – patients with
prediabetes; D – patients with type 2 diabetes mellitus (T2DM). TCS – total comet score. *p < 0.05; **p < 0.01; *** p<0.001 (Bonferroni test).
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2.7. Statistical analysis
Due to the homogeneity of the data obtained in the Comet assay
(coefficient of variation< 30%), one-way analysis of variance
(ANOVA) was used, followed by Bonferroni test. Basic antropometric
and biochemical analysis among groups were analysed by one-way
ANOVA and Tukey’s test. Statistical significance of the differences of
catalase, TBARS and LDH was determined by means of the ANOVA test
followed by Dunnett test. The area under the curve (AUC) was calcu-
lated with baseline adjusted for all groups and parameters, followed by
Kruskall-Wallis and Dunn`s test for heterogenous dateset, while for
homogeneous dataset we used one-way ANOVA and post hoc Tukey’s
test. Statistical analysis was performed with GraphPad Prism version 6
(GraphPad, San Diego, CA, USA). All values are presented as the
mean ± SE. A p value of less than 0.05 was considered to be statisticaly
significant.
3. Results
The basic clinical characteristics of study groups are shown in
Table 1. The groups were homogenous for all parameters (age, FPG,
HbA1c, blood pressure, BMI). Homogenous results for FPG and HbA1c
demonstrate that all subjects had good glycaemic control, which was
supported by medication in prediabetics and diabetics. Also, none of the
subjects involved in this study had a history of some serious medical
condition connected to diabetes complications (stroke, heart attack,
cancer, absence of any systemic disease or infection in previous
months).
At all experimental points, the cell viability in Trypan blue exclu-
sion test was acceptable (over 85%). The results of primary DNA
Table 1
Basic characteristics of the study groups.
Parameters Normal Obese Prediabetics T2DM
Age (years) 53.00 ± 3.54 61.00 ± 1.41 53.83 ± 2.27 57.00 ± 2.94
FPG (mmol/L) 5.16 ± 0.30 5.30 ± 0.22 5.57 ± 0.17 5.45 ± 0.33
HbA1c (%) 5.68 ± 0.16 6.05 ± 0.29 5.70 ± 0.11 6.05 ± 0.19
BM (kg) 70.78 ± 9.72 84.65 ± 2.96 85.30 ± 8.77 78.75 ± 6.65
BH (cm) 165.20 ± 2.52 167.00 ± 2.74 165.67 ± 4.12 175.50 ± 3.84
BMI (kg/m2) 26.16 ± 3.46 30.4 ± 0.27 30.77 ± 2.40 25.40 ± 1.27
Systolic BP (mmHg) 124.00 ± 4.00 132.50 ± 10.31 121.67 ± 9.10 122.50 ± 2.50
Dyastolic BP (mmHg) 82.00 ± 2.00 82.50 ± 4.79 76.67 ± 5.58 80.00 ± 0.00
The results are presented as mean ± SE; FPG- fasting plasma glucose; BM – body mass; BH- body height; BMI – body mass index; BP- blood pressure. There were no
statistically significant differences among groups for any analysed parameter (p>0.05 in one-way ANOVA and Tukey’s test).
Fig. 2. Activity of catalase (CAT) in PBMCs of A) normal, B) obese C) prediabetics D) T2DM persons treated with vireos concentrations of adrenaline and positive
control (H2O2). The results are presented as means ± standard error of mean (SEM). *p < 0.05 in comparison to the negative control (zero point), by Dunnett test.
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damage in various groups (healthy, obese, prediabetics and T2DM pa-
tients) are presented in Fig. 1. In healthy individuals only the highest
concentration of adrenaline (10μM) exerted significant increase
(p < 0.001) in DNA damage which is reflected in higher value of TCS
score compared to untreated cells (A). However, in PBMCs of obese
individuals significant increase in DNA damage was noted at 1 μM
(p < 0.01) and 10 μM concentration of adrenaline (p < 0.001), (B).
Similar results were observed in the prediabetic and T2DM groups were
1 μM of adrenaline induce significant rise (p < 0.05) in DNA migra-
tion, while the highest concentration of adrenaline (10 μM) caused an
obvious DNA damaging effect (p < 0.001) compared to untreated cells
(C,D). As expected, in all tested groups the positive control (100 μM
H202) caused highly significant DNA damage (p < 0.001) in PBMCs. In
summary, the basic difference in reactivity to adrenaline among the
investigated groups is noticed at its concentration of 1 μM since PBMCs
from normal persons did not have increased TCS score, whereas PBMCs
from all other groups had at least slightly significant increase of TCS
score. Interestingly, 10-fold higher concentration of adrenaline (10 μM)
caused highly significant DNA damage in all groups of analysed per-
sons.
The results of catalase activity are presented on Fig. 2. There was a
statistically significant decrease of catalase activity in PBMCs from
prediabetics and T2DM patients after the treatment with high con-
centrations of adrenaline (1 and 10 μM) in comparison to the negative
control. Namely, the activity of the enzyme was lowered by 27.40% and
32.56% (p < 0.05) in prediabetics, while 31.68% and 34.50%
(p < 0.05) in diabetic patients. Roughly the same percentage of cata-
lase inhibition was caused by hydrogen peroxide in both groups of
subjects (p < 0.05).
In order to examine the influence of increased ROS on the level of
cell membrane damage in the PBMCs of the examined subjects (normal,
obese, prediabetics and T2DM), under the influence of various con-
centrations of adrenaline in vitro, we determined the concentrations of
TBARS, as well as activity of LDH as a specific marker of cell membrane
damage in PBMCs [30].
The results of the effects of various concentrations of adrenaline on
cell membrane damage are presented in the Fig. 3.
In healthy person PBMCs there was a weak increase at all tested
concentrations, but it did not reach statistical significance in compar-
ison to the negative control level. In PBMCs of obese subjects there was
a significant increase of membrane lipids damage at higher con-
centrations of adrenaline: 1 and 10 μM (p < 0.05 and p < 0.01). The
examined concentrations of adrenaline caused an increase of lipid
peroxidation in prediabetics with the level of significance of p < 0.05
(0.1 and 1 μM adrenaline) and p < 0.01 (10 μM adrenaline). However,
in T2DM subjects all concentrations of adrenaline caused an obvious
damage of membrane lipids at the level of statistical significance of
p < 0.001. The concentration of TBARS was increased in comparison
to the untreated PBMCs for 55.7%, 70.90% and 95.15% (confidence
interval, CI 95%) for increasing concentrations of adrenaline of 0.1, 1
and 10 μM, respectively. In summary, significant differences between
the investigated groups with respect to harmful effects of adrenaline on
the cell membrane were most obvious in diabetic patients. PBMCs
treated with hydrogen peroxide had also damage of cell membrane, and
the level of statistical significance was different: p < 0.01 in obese,
p < 0.05 in prediabetics and p < 0.001 in T2DM patients.
Fig. 3. Concentration of thiobarbituric acid reactive substances (TBARS) as an indicator of lipid peroxidation in PBMCs of A) normal, B) obese, C) prediabetics and D)
T2DM patients treated with various concentrations of adrenaline and the positive control (H2O2). The results are presented as means ± SEM. *p < 0.05, **p <
0.01; ***p < 0.001 in comparison to the negative control, by Dunnett test.
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The results of the amount of released enzyme lactate dehydrogenase
in all investigated groups are presented in Fig. 4.
On the basis of the amount of this enzyme we can conclude that
there is a tendency of release of LDH in all groups treated with various
doses of adrenaline with a high level of statistical significance. The most
intensive changes are obtained in prediabetics and T2DM groups
treated with concentrations of 0.1 μM (p < 0.01) and 1 μM of adre-
naline (p < 0.001), with a maximal activity at 10 μM of adrenaline
(p < 0.001). The same effect was observed with H2O2 (p < 0.001).
Results of the analysis of area under the curve (AUC) for each in-
vestigated parameter are presented at the Fig. 5. On the basis of the
obtained results it is obvious that total comet score (TCS) is increased
(p < 0.0001) in all investigated groups (obese, prediabetics and dia-
betics) when compared to normal subjects. Prediabetics and T2DM
groups had increased level of cell membrane damage (AUC of TBARS,
AUC of LDH) in comparison to normal and obese persons with various
levels of statistical significance (Fig. 5). On the other hand, increase of
AUC for CAT was observed in prediabetics (p < 0.05) and T2DM group
(p < 0.001), compared to the control and obese subjects.
4. Discussion
It is well established that diabetes is associated with increased
production of reactive oxygen species (ROS) which is one of the most
important factors for the disease progression and development of
chronic complications [11,31]. In addition to decreased level of oxi-
dative DNA damage, diabetics have lower capacity of antioxidative
defence mechanisms [32].
In this study, we treated isolated human PBMCs with three
concentrations of adrenaline (0.1, 1 and 10 μM). These concentrations
are much higher than therapeutic doses of adrenaline for treatment of
cardiac arrest. We chose these concentrations to build on previous in
vitro results that we have published [33]. All concentrations of adre-
naline in our investigation were much higher than blood adrenaline in
some severe pathophysiological conditions such as pheochromocytoma.
However, the highest concentration of 10 μM is much lower than
highest possible concentration (10mM) recommended for in vitro
Comet assay of relatively untoxic compounds [22].
It should be mentioned that dose of adrenaline depends not only on
its concentration but also on the treatment duration. In our previous
investigation [33] of genotoxic effects of adrenaline on PBMCs even the
concentration of 0.001 μM was high enough to produce significant DNA
damage after 15min of treatment, while after 1 h the concentration of 5
μM was high enough to increase DNA migration in the Comet assay. In
the present investigation, an intermediate time of 30min was good
enough to make 1 μM of adrenaline to cause a significant level of DNA
damage. Therefore, at shorter time of treatment DNA damage is not
repaired enough giving the increased level of DNA damage in the
Comet assay.
The increased DNA damage under the influence of adrenaline was
evident at a concentration of 1 μM in obese, prediabetic and diabetic
persons, showing that their PBMCs are more sensitive to genotoxic ef-
fects of adrenaline, despite the fact that all our subjects had good gly-
caemic control. Namely, impared glucose regulation causes higher level
of DNA damage, especially in patients diagnosed with T2DM [34,35].
Since only normal subjects in our investigation did not respond to in-
termediate dose (1 μM) of adrenaline in the Comet assay, even the
obesity is a risk factor for increased sensitivity of PBMCs to DNA
Fig. 4. Extracellular lactate dehydrogenase activity (LDH) as an indicator of cell cytotoxicity in PBMCs of A) normal, B) obese, C) prediabetics and D) T2DM, treated
with various concentrations of adrenaline and positive control (H2O2). The results are presented as means ± SEM. **p < 0.01; ***p < 0.001 in comparison to the
negative control group, by Dunnett test.
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damaging effects of adrenaline. Indeed, there is an association between
oxidative stress and obesity [36] and it is not surprising that obesity has
contribution in the etiopathogenesis of diabetes mellitus [37].
There are experimental findings [38] that adrenaline causes greater
increase of plasma glucose in obese than in non-obese mice, while
plasma insulin level decreased only in obese animals after administra-
tion of adrenaline. This implies significant role of hyperglycemia in
oxidative DNA damage. Indeed, there is a reduction of DNA damage
after insulin treatment [39], whereas hyperglycemia may accelerate
ROS through glucose oxidation pathway [40]. Bearing in mind that the
T2DM group has higher blood glucose than prediabetics and obese
groups it is not surprising that diabetics are most susceptible to oxi-
dative DNA damage. This type of damage in our study is even more
pronounced after adrenaline administration. Interestingly, despite
harmful effects due to ROS production, adrenaline may have some
beneficial effects in diabetic patients by increasing the glucagone se-
cretion which may mitigate the sudden hypoglycemia [41] Hamilton
et al., 2018).
Adrenaline caused increased DNA damage possibly by production of
reactive oxygen species (ROS), as demonstrated in our previous in-
vestigations [16,33]. The possible mechanisms underlying this ROS
production may include redox cycling of adrenaline [19] and/or sti-
mulation of β2 adrenoceptors [18].
In order to determine the effect of adrenaline on antioxidative status
in all tested group we evaluated activity of CAT. Analyzing the PBMCs
catalase activity, we noticed a weak increase of the activity of this
enzyme in control and obese groups. A high level of catalase enables
lower hydrogen peroxide production in cells and therefore prevents
oxidative damage [42]. A decrease in catalase activity can be the result
of inactivation of the enzyme. Decreased activity of catalase can lead to
a numerous harmful effects due to accumulation of superoxide anion
and hydrogen peroxide [43].
By comparison of the values between control and obese subjects, we
observed a higher initial levels of activities of enzymes in prediabetic
and diabetic groups. These results are in accordance with a study of
Cericllo et al. [44] showing that biomarkers of oxidative stress, in-
cluding the activity of catalase, are increased in T2DM patients. The
hyperglycemia itself is gradually established during the period of pre-
diabetes and it causes an additional increase of free radical production.
In this study, we showed that after the treatment of PBMCs with
various concentrations of adrenaline or H2O2 activity of catalase is
decreased. Therefore, the antioxidative capacity of the cell is lowered
and production of free radicals is increased, and all of that results in
redox homeostasis disorder [4].
The end products of lipid peroxidation are extremely reactive and
cause a consecutive chain propagation and oxidation of nearby poly-
unsaturated fatty acid (PUFA). It has been shown that products of lipid
peroxidation can be transported from the site of their formation to the
other sites in organism, acting as secondary cytotoxic signalling mole-
cules – signals that transfer an information about the origin of primary
oxidative reaction [45]. An extent of lipid peroxidation in examined
patients was monitored by concentration TBARS including of MDA, one
of the end products of cyclic reaction of lipid peroxidation as a marker
of oxidative damage in cells. MDA is especially important product be-
cause it has mutagenic effects in mammalian cells and carcinogenic
effect in rodents [3]. Our results have shown increased levels of TBARS
Fig. 5. Results of the analysis of area under the curve (AUC) – comparisons among groups for each of investigated parameters: (A) TCS in the Comet assay; (B)
catalase; (C) TBARS and (D) LDH.
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at all three concentrations of adrenaline in vitro, and in all examined
groups of patients in comparison to the negative control, except for the
control group. The most profound changes were detected in T2DM
group, at all concentrations of adrenaline (Fig. 3). Increased TBARS
were noticed in T2DM in correlation with duration of the illness and
development of complications [46]. Alvarez-Diduk and Galano [47]
suggest that catecholamines (adrenaline and noradrenaline) play role as
protectors and molecular targets of oxidative stress.
PBMCs from T2DM patients exhibited production of ROS and da-
mage of cell membranes [48]. Adrenaline exerts a similar effect in re-
gard to TBARS level. In this investigation all tested concentrations of
adrenaline in D2MT subjects induced significant enhancement of level
of TBARS in comparison to control. In addition, the significant increase
in TBARS level was found in prediabetic and T2DM group after treat-
ment with highest concentration of adrenaline. Previous studies have
reported increased levels of lipid peroxide in nonobese T2DM subject
[49]. On other hand, there is evidence that treatment with adrenaline
may result in significant increment of lipid peroxidation [50]. Therefore
increased TBARS level significes on disrupted of redox homeostasis as
result of adrenaline influence. Besides, the observed DNA damage may
derive from lipid peroxidation, since MDA has the ability to react with
DNA and form exocyclic adducts such as mutagenic pyrimidopurinone.
Respectively, lipid peroxidation may be important mediators of DNA
damage related with oxidative stress caused by reactions of adrenaline
and higher level of glucose.
The PBMCs membrane damage in this study was indirectly also
monitored through the amount of release of the enzyme lactate dehy-
drogenase from cells. LDH is a strictly intracellular enzyme, the damage
of cell membranes in tissues causes leak of cytoplasmic enzyme LDH
from cells. Therefore, spontaneous LDH release and the level of LDH
extracellular activity can be used to estimate which tissue is damaged
and to what extent [51]. In all experimental groups in this investiga-
tion, we observed increased amounts of extracellular LDH, pointing to
unambiguously increased damage of PBMCs membranes.
The produced reactive oxygen species start the lipid peroxidation
interacting with PUFA, which concentration is the highest in cell
membranes of parenhymatic organs in T2DM [5]. That is why it is
important to monitor parameters of oxidative damage such as hydrogen
peroxide content, which directly give an answer about formation of
hydroxyl radical that can lead to disturbed cell functioning resulting
with mutagenesis and carcinogenesis [52]. However, further studies are
needed to unravel the exact mechanisms underlying adrenaline induced
genotoxicity.
5. Conclusions
PBMCs of obese, prediabetic and T2DM persons are more prone to
DNA damage after in vitro treatment with adrenaline in comparison to
those of healthy individuals. Also, in these groups of patients adrenaline
causes a higher increase in oxidative stress and damage of cell mem-
brane in vitro in comparison to the healthy group.
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